DYNE-101
DYNE101-DM1-201
Phase 2 small_molecule active
Quick answer
DYNE-101 for Myotonic Dystrophy Type 1 (DM1) is a Phase 2 program (small_molecule) at Dyne Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dyne Therapeutics
- Indication
- Myotonic Dystrophy Type 1 (DM1)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active